Intratumor heterogeneity has been demonstrated in a wide range of experimental and human neoplasms. In general, this has been done by isolating tumor subpopulations from single neoplasms and showing them to differ in many characteristics including sensitivity to antineoplastic drugs. We have developed a mouse mammary tumor model system to study the principles of tumor heterogeneity. This system consists of a series of tumor subpopulation lines and sublines, all of which derive ultimately from the same parental tumor. One of the major conclusions of our work is that isolated subpopulations may behave differently when grown alone than they do when they are in each other's presence. Tumor subpopulation interactions confer a societal aspect to cancer growth and behavior. Studies designed to understand the role of tumor heterogeneity in any phenotype need to take the tumor's """"""""ecosystem"""""""" into account. In the current grant period we developed an in vitro collagen gel assay to evaluate the sensitivity of tumors to chemotherapeutic drugs. This assay is based on the concepts of tumor heterogeneity including zonal distribution of tumor subpopulations and subpopulation interactions that alter drug response. We are also developing a series of subpopulation lines, companions to the mammary tumor lines of our model system, but which contain specific genetic markers that allow us to quantitate them in mixed populations. Using these lines and our new in vitro assay, we propose to reconstruct heterogeneous tumors by mixing subpopulations that differ in chemosensitivity and in ability to interact with each other and to use the reconstructed tumors to examine the significance of tumor heterogeneity on in vitro and in vivo sensitivity to chemotherapeutic drugs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA027419-07
Application #
3167612
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1979-09-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
7
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Barbara Ann Karmanos Cancer Institute
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48201
Miller, B E; Matherly, L H; Lehotan, M et al. (1996) Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures. J Exp Ther Oncol 1:30-8
Miller, B E; Miller, F R; Machemer, T et al. (1993) Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour. Br J Cancer 68:18-25
Heppner, G H (1993) Cancer cell societies and tumor progression. Stem Cells 11:199-203
Miller, B E; Machemer, T; Lehotan, M et al. (1991) Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Res 51:4378-87
Aslakson, C J; McEachern, D; Conaway, D H et al. (1991) Inhibition of lung colonization at two different steps in the metastatic sequence. Clin Exp Metastasis 9:139-50
Aslakson, C J; Rak, J W; Miller, B E et al. (1991) Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis. Int J Cancer 47:466-72
Welch, D R; Bisi, J E; Miller, B E et al. (1991) Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 47:227-37
Heppner, G H (1991) Cell-to-cell interaction in regulating diversity of neoplasms. Semin Cancer Biol 2:97-103
Miller, F R; McEachern, D; Miller, B E (1990) Efficiency of communication between tumour cells in collagen gel cultures. Br J Cancer 62:360-3
Miller, F R; Heppner, G H (1990) Cellular interactions in metastasis. Cancer Metastasis Rev 9:21-34

Showing the most recent 10 out of 22 publications